We help patients, who develop leukaemia & similar disorders, and who are treated in Plymouth, by providing equipment and facilities to enable them to have the best possible care and support.
Registered Charity 290480
17th March 2020
The Annual General Meeting this year was going to be on Wednesday April 22nd, but in view of the ongoing Coronavirus situation and that several people attending would be in the high risk category or medical staff engaged in looking after ill patients, the Trustees decided that in these exceptional circumstances, the AGM will be cancelled. When fully signed off, we will post the Annual Report and the Financial Statement on the website. They will also be sent to the Charity Commission. A letter will be sent to members shortly.
We are sorry that this meeting will not take place. If you have any queries, comments or suggestions please get in contact with one of us.
Adrian Copplestone, Chair of Trustees
8th April 2020
The annual return has been made to the Charity Commission and the Financial Statement and Trustee Annual Report are posted on the AGM page. These documents are usually presented at the AGM. I have also posted the latest newsletter on the Newsletter page. Thank you to Lesley Teasdale for preparing this – she is always keen to have your contributions. The newsletter is being sent to members. Adrian Copplestone
People who develop Leukaemia (and similar disorders: e.g. Lymphomas, Multiple Myeloma, Myelodysplastic Syndromes & Myeloproliferative Diseases) require complicated treatments and often require long spells in hospital. PDLF helps by providing equipment and facilities that are not available on the NHS, to enable them to have the best possible care and support. Some patients come from further afield in the South West Peninsula for Stem Cell Transplants.
With the help of patients, relatives and volunteers, PDLF has raised over £1.8 million in the last 30 years and helped set up Stem Cell Transplantation & Molecular Biology and helped create better inpatient facilities and a new Day Case Unit. Very little money is spent on administration and expenses: only insurance, licences and other requirements.
PDLF also supports research into malignant haematological diseases and this helps in the diagnosis and management of these illnesses.
It is easy to become a member of PDLF.
Simply email the Membership Secretary Joanna Farrugia with details of your name, address and email address. It is also helpful to give us some information on your interest in the Fund.
Membership fees are £5 annually, Families £7.50 annually.
Newsletters are sent out periodically and can be found on our News page.
The Annual General Meeting is held in April, and is a chance to meet other members.
Research is important because it stimulates people to think about new approaches and keep up to date. Haematology has been a rapidly developing field over the last 50 years, with many of the successes in understanding and treating cancer coming from research on blood diseases.
Plymouth has always been actively involved in Clinical Trials in both national treatment schedules and the use of new drugs. Professor Simon Rule heads up the Research Office, which is currently running 30 clinical trials.
PDLF has been pleased to fund research over the years
PDLF has also funded 4 PhDs and has just approved another; the supervisor is Dr Claire Hutchinson.
PDLF has also set up the Molecular Biology Laboratory and all the facilities for separating, culturing, freezing and storing Stem Cells for clinical use. In recent years, this has been outsourced to a commercial provider.
Chairman & Secretary
Research Trials Office
We currently have two vacancies and we are looking for a Treasurer
We’re friendly and available to help, please reach out to us anytime and we’ll happily answer your questions.